• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

泌尿系统癌症的分子研究与治疗

Molecular Research and Treatment of Urologic Cancer.

作者信息

Yamashita Hironobu

机构信息

Department of Pathology and Laboratory Medicine, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.

出版信息

Int J Mol Sci. 2024 Dec 20;25(24):13666. doi: 10.3390/ijms252413666.

DOI:10.3390/ijms252413666
PMID:39769426
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11728087/
Abstract

Urologic cancers exhibit tumor heterogeneity in their morphology, gene expression, and phenotypic features, and have different responses to drug treatment [...].

摘要

泌尿系统癌症在形态学、基因表达和表型特征方面表现出肿瘤异质性，并且对药物治疗有不同的反应[……]。

相似文献

1
Molecular Research and Treatment of Urologic Cancer.泌尿系统癌症的分子研究与治疗
Int J Mol Sci. 2024 Dec 20;25(24):13666. doi: 10.3390/ijms252413666.
2
Status and prospects of gene therapy for urologic cancer.
Mol Urol. 2000 Summer;4(2):39-40. doi: 10.1089/10915360050138549.
3
Application of antisense technology to urologic cancers.
Mol Urol. 2000 Summer;4(2):55-9. doi: 10.1089/10915360050138594.
4
Gene therapy for urologic cancer.
Urology. 1994 Oct;44(4):617-24. doi: 10.1016/s0090-4295(94)80075-8.
5
Genomic Sequencing Should Be Part of the Standard of Care for Most Urologic Cancers: For.基因组测序应该成为大多数泌尿科癌症标准治疗的一部分：美国泌尿外科学会（AUA）临床指南。
Eur Urol Focus. 2022 May;8(3):637-638. doi: 10.1016/j.euf.2022.06.013. Epub 2022 Jul 8.
6
Epigenetics of Urological Cancers.泌尿系统肿瘤的表观遗传学。
Int J Mol Sci. 2019 Sep 26;20(19):4775. doi: 10.3390/ijms20194775.
7
Status and prospects of gene therapy for urologic cancer. First Meeting of the Japanese Society for Urological Gene Therapy. November 20, 1999. Okayama, Japan.
Mol Urol. 2000 Summer;4(2):37-87.
8
The systemic therapy of urologic cancer.泌尿系统癌症的全身治疗。
Conn Med. 1980 Apr;44(4):217-24.
9
[Diagnosis and Treatment of MSI-H Cancer in the Urological Malignancy].
Gan To Kagaku Ryoho. 2018 Nov;45(11):1573-1576.
10
Molecular medicine and its impact on practice.
Nat Clin Pract Urol. 2005 Feb;2(2):59. doi: 10.1038/ncpuro0098.

本文引用的文献

1
Analysis of the Gene Networks and Pathways Correlated with Tissue Differentiation in Prostate Cancer.分析与前列腺癌组织分化相关的基因网络和途径。
Int J Mol Sci. 2024 Mar 24;25(7):3626. doi: 10.3390/ijms25073626.
2
Elevated Plasma Concentration of 4-Pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR) Highlights Malignancy of Renal Cell Carcinoma.血浆 4-吡啶酮-3-羧酰胺-1-β-D-核糖核苷（4PYR）浓度升高提示肾癌恶性程度高。
Int J Mol Sci. 2024 Feb 17;25(4):2359. doi: 10.3390/ijms25042359.
3
Mini-Review: Current Bladder Cancer Treatment-The Need for Improvement.综述：当前膀胱癌治疗——亟待改进。
Int J Mol Sci. 2024 Jan 26;25(3):1557. doi: 10.3390/ijms25031557.
4
The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy.密勒胺受体 MrgD 在肾透明细胞癌中的表达与预后不良和对抗血管生成治疗反应不佳相关。
Int J Mol Sci. 2024 Jan 25;25(3):1499. doi: 10.3390/ijms25031499.
5
ERVK13-1/miR-873-5p/GNMT Axis Promotes Metastatic Potential in Human Bladder Cancer though Sarcosine Production.ERVK13-1/miR-873-5p/GNMT 轴通过肌氨酸生成促进人膀胱癌的转移潜能。
Int J Mol Sci. 2023 Nov 15;24(22):16367. doi: 10.3390/ijms242216367.
6
The Effect of Photosensitizer Metalation Incorporated into Arene-Ruthenium Assemblies on Prostate Cancer.芳基金属钌配合物中光增敏剂金属化对前列腺癌的影响。
Int J Mol Sci. 2023 Sep 2;24(17):13614. doi: 10.3390/ijms241713614.
7
Tumor Heterogeneity and Consequences for Bladder Cancer Treatment.肿瘤异质性及其对膀胱癌治疗的影响
Cancers (Basel). 2021 Oct 22;13(21):5297. doi: 10.3390/cancers13215297.